Jakhar J, Mehta UM, Ektare A, et al. Cortical inhibition in major depression: investigating the acute effect of single-session yoga versus walking[J]. Brain Stimul, 2019, 12(6):1597-1599.

Rossini PM, Burke D, Chen R, et al. Non-invasive electrical and magnetic stimulation of the brain, spinal cord, roots and peripheral nerves: Basic principles and procedures for routine clinical and research application. An updated report from an I. F. C. N. Committee[J]. Clin Neurophysiol, 2015, 126(6):1071-1107.

唐莺莹, 李惠, 王继军. 经颅磁技术评估基于γ-氨基丁酸能神经通路的大脑皮质活动的研究进展[J]. 中华精神科杂志, 2013, 46(6):383-384.

Candido-Santos L, Gushken F, Gadotti GM, et al. Intracortical inhibition in the affected hemisphere in limb amputation[J]. Front Neurol, 2020, 11:720.

Noda Y, Barr MS, Zomorrodi R, et al. Evaluation of short interval cortical inhibition and intracortical facilitation from the dorsolateral prefrontal cortex in patients with schizophrenia[J]. Sci Rep, 2017, 7(1):17106.

Premoli I, Castellanos N, Rivolta D, et al. TMS-EEG signatures of GABAergic neurotransmission in the human cortex[J]. J Neurosci, 2014, 34(16):5603-5612.

Noda Y, Zomorrodi R, Cash RF, et al. Characterization of the influence of age on GABAA and glutamatergic mediated functions in the dorsolateral prefrontal cortex using paired-pulse TMS-EEG[J]. Aging(Albany NY), 2017, 9(2):556-572.

Radhu N, Ravindran LN, Levinson AJ, et al. Inhibition of the cortex using transcranial magnetic stimulation in psychiatric populations: current and future directions[J]. J Psychiatry Neurosci, 2012, 37(6):369-378.

Jeng JS, Li CT, Lin HC, et al. Antidepressant-resistant depression is characterized by reduced short-and long-interval cortical inhibition[J]. Psychol Med, 2020, 50(8):1285-1291.

Veronezi BP, Moffa AH, Carvalho AF, et al. Evidence for increased motor cortical facilitation and decreased inhibition in atypical depression[J]. Acta Psychiatr Scand, 2016, 134(2):172-182.

Lissemore JI, Bhandari A, Mulsant BH, et al. Reduced GABAergic cortical inhibition in aging and depression[J]. Neuropsychopharmacology, 2018, 43(11):2277-2284.

Lewis CP, Nakonezny PA, Blacker CJ, et al. Cortical inhibitory markers of lifetime suicidal behavior in depressed adolescents[J]. Neuropsychopharmacology, 2018, 43(9):1822-1831.

Lewis CP, Camsari DD, Sonmez AI, et al. Preliminary evidence of an association between increased cortical inhibition and reduced suicidal ideation in adolescents treated for major depression[J]. J Affect Disord, 2019, 244:21-24.

Voineskos D, Blumberger DM, Zomorrodi R, et al. Altered transcranial magnetic stimulation-electroencephalographic markers of inhibition and excitation in the dorsolateral prefrontal cortex in major depressive disorder[J]. Biol Psychiatry, 2019, 85(6):477-486.

Dhami P, Atluri S, Lee JC, et al. Prefrontal cortical reactivity and connectivity markers distinguish youth depression from healthy youth[J]. Cereb Cortex, 2020, 30(7):3884-3894.

Carment L, Dupin L, Guedj L, et al. Neural noise and cortical inhibition in schizophrenia[J]. Brain Stimul, 2020, 13(5):1298-1304.

Mehta UM, Thirthalli J, Basavaraju R, et al. Association of intracortical inhibition with social cognition deficits in schizophrenia: findings from a transcranial magnetic stimulation study[J]. Schizophr Res, 2014, 158(1-3):146-150.

Strube W, Wobrock T, Bunse T, et al. Impairments in motor-cortical inhibitory networks across recent-onset and chronic schizophrenia: a cross-sectional TMS study[J]. Behav Brain Res, 2014, 264:17-25.

Bridgman AC, Barr MS, Goodman MS, et al. Deficits in GABAA receptor function and working memory in non-smokers with schizophrenia[J]. Schizophr Res, 2016, 171(1-3):125-130.

Wobrock T, Hasan A, Malchow B, et al. Increased cortical inhibition deficits in first-episode schizophrenia with comorbid cannabis abuse[J]. Psychopharmacology(Berl), 2010, 208(3):353-363.

Tang Y, Zhang T, Edelman B, et al. Prolonged cortical silent period among drug-naive subjects at ultra-high risk of psychosis[J]. Schizophr Res, 2014, 160(1-3):124-130.

Hasan A, Wobrock T, Grefkes C, et al. Deficient inhibitory cortical networks in antipsychotic-naive subjects at risk of developing firstepisode psychosis and first-episode schizophrenia patients: a cross-sectional study[J]. Biol Psychiatry, 2012, 72(9):744-751.

Radhu N, Dominguez LG, Greenwood TA, et al. Investigating cortical inhibition in first-degree relatives and probands in schizophrenia[J]. Sci Rep, 2017, 7:43629.

Radhu N, Garcia Dominguez L, Farzan F, et al. Evidence for inhibitory deficits in the prefrontal cortex in schizophrenia[J]. Brain, 2015, 138(Pt 2):483-497.

Basavaraju R, Sanjay TN, Mehta UM, et al. Cortical inhibition in symptomatic and remitted mania compared to healthy subjects: a cross-sectional study[J]. Bipolar Disord, 2017, 19(8):698-703.

Ruiz-Veguilla M, Martín-Rodríguez JF, Palomar FJ, et al. Traitand state-dependent cortical inhibitory deficits in bipolar disorder[J]. Bipolar Disord, 2016, 18(3):261-271.

陈珊, 唐莺莹, 王继军, 等. 双相障碍躁狂发作患者皮层抑制功能改变[J]. 中国神经精神疾病杂志, 2020, 46(9):526-530.

Goodman MS, Bridgman AC, Rabin RA, et al. Differential effects of cannabis dependence on cortical inhibition in patients with schizophrenia and non-psychiatric controls[J]. Brain Stimul, 2017, 10(2):275-282.

Richter MA, de Jesus DR, Hoppenbrouwers S, et al. Evidence for cortical inhibitory and excitatory dysfunction in obsessive compulsive disorder[J]. Neuropsychopharmacology, 2012, 37(5):1144-1151.

Chandra SR, Issac TG, Nagaraju BC, et al. A study of cortical excitability, central motor conduction, and cortical inhibition using single pulse transcranial magnetic stimulation in patients with early frontotemporal and Alzheimer's dementia[J]. Indian J Psychol Med, 2016, 38(1):25-30.

Enticott PG, Kennedy HA, Rinehart NJ, et al. GABAergic activity in autism spectrum disorders: an investigation of cortical inhibition via transcranial magnetic stimulation[J]. Neuropharmacology, 2013, 68:202-209.

Deniz DC, Lewis CP, Irem SA, et al. Transcranial magnetic stimulation markers of antidepressant treatment in adolescents with major depressive disorder[J]. Int J Neuropsychopharmacol, 2019, 22(7):435-444.

Croarkin PE, Nakonezny PA, Husain MM, et al. Evidence for pretreatment LICI deficits among depressed children and adolescents with nonresponse to fluoxetine[J]. Brain Stimul, 2014, 7(2):243-251.

Lissemore JI, Mulsant BH, Rajji TK, et al. Cortical inhibition, facilitation and plasticity in late-life depression: effects of venlafaxine pharmacotherapy[J]. J Psychiatry Neurosci, 2021, 46(1):E88-E96.

Casarotto S, Canali P, Rosanova M, et al. Assessing the effects of electroconvulsive therapy on cortical excitability by means of transcranial magnetic stimulation and electroencephalography[J]. Brain Topogr, 2013, 26(2):326-337.

Sun Y, Farzan F, Mulsant BH, et al. Indicators for remission of suicidal ideation following magnetic seizure therapy in patients with treatment-resistant depression[J]. JAMA Psychiatry, 2016, 73(4):337-345.

Gordon PC, Valiengo L, de Paula V, et al. Changes in motor cortical excitability in schizophrenia following transcranial direct current stimulation[J]. Prog Neuropsychopharmacol Biol Psychiatry, 2019, 90:43-48.

Ustohal L, Mayerova M, Hublova V, et al. Risperidone increases the cortical silent period in drug-naive patients with first-episode schizophrenia: a transcranial magnetic stimulation study[J]. J Psychopharmacol, 2017, 31(4):500-504.

Frank E, Landgrebe M, Poeppl TB, et al. Antipsychotic treatment with quetiapine increases the cortical silent period[J]. Schizophr Res, 2014, 156(1):128-132.

Schecklmann M, Weidler C, Eichhammer P, et al. Increased shortinterval intracortical inhibition in un-medicated patients with schizophrenia[J]. Brain Stimul, 2018, 11(5):1080-1082.